• Home
  • About Us
  • Blog

Pulmonary Hypertension RN

  • What is Pulmonary Hypertension?
    • What is Pulmonary Hypertension?
    • Pulmonary Hypertension Symptoms
    • Types of Pulmonary Hypertension
    • Causes of Pulmonary Hypertension
    • PH vs. PAH
    • Diastolic Heart Failure vs. PAH
    • WHO Group 3 Pulmonary Hypertension, IPF & COPD
    • Pulmonary Veno-Occlusive Disease
    • Hereditary Hemorrhagic Telangiectasia (HHT)
      • Hereditary Hemorrhagic Telangiectasia (HHT) Treatment
    • Functional Classification of Pulmonary Hypertension
    • Congenital Heart Disease
      • Eisenmenger’s Syndrome
      • Update on Management of PAH-CHD
      • Congenital Heart Disease & Sleep Apnea
      • Complex Congenital Heart Disease
      • Atrial Septal Defect and Pulmonary Arterial Hypertension
    • Pediatric Pulmonary Arterial Hypertension
    • Sickle Cell and Pulmonary Hypertension
    • Stimulant Associated Pulmonary Arterial Hypertension
    • Porto-Pulmonary Syndrome
    • Research, Life Expectancy & Prognosis for PH
  • Diagnosing & Monitoring PAH
    • Pulmonary Arterial Hypertension Diagnosis
    • How Am I Doing? Assessing Your PAH.
    • Blood Tests
    • Cardiopulmonary Exercise Test (CPET)
    • CT (Computed Tomography) Scan
    • Echocardiogram: An Overview
    • Echocardiogram: A Detailed Look
    • Pulmonary Function Tests (PFTs)
    • Right Heart Catheterization
    • Six Minute Walk
    • Ventilation Perfusion Scan (VQ Scan)
    • CTEPH
      • CTEPH: WHO Group 4 Pulmonary Hypertension
      • PTE (Pulmonary Thromboendarterectomy) Surgery
      • Adempas used to Treat PAH and CTEPH
  • PAH Treatment
    • Pulmonary Hypertension Centers
    • Pulmonary Hypertension Treatments
    • Continuously Infused Therapies Used to Treat PH
    • Prostanoids for Treatment of PH
    • Adcirca and Revatio Used to Treat Pulmonary Arterial Hypertension (PAH)
    • Adempas used to Treat PAH and CTEPH
    • Tracleer, Letairis, and Opsumit Treatments
    • Oxygen Therapy for Pulmonary Hypertension
    • Salt and Water Restrictions
    • Exercise & PAH
    • Diuretics
    • Blood Thinners
    • Getting the Most Out of PAH Therapy
      • Letairis
      • Opsumit
      • Sildenafil (Revatio)
  • Research
  • FAQ’s
    • Implanted Remodulin Pump, Right Heart Catheterization, PAH & Pregnancy
    • Oral Treatments, Care Centers & Hole in Heart
    • FAQ’s: Altitude, Cold & Allergy Medications
    • FAQ’s: Psoriasis, Idiopathic PAH, Contraceptives & PAH
    • FAQ’s: Causes of Pulmonary Hypertension, Symptom Frequency & Care Centers
    • FAQ: PAH Experts, Pregnancy, Mild PAH & Vacationing
    • FAQ’s: CTEPH, Blood Clots, Corrective Surgery & PAH Care Centers
    • FAQ’s: VQ Scans & PAH Curable?
    • FAQ’s: Mild Pulmonary Hypertension?
    • FAQ’s: Boating, Swimming & Eating with PAH
    • FAQ’s: Borderline Pulmonary Hypertension, Hand Swelling, Children with PAH, Costs

About Us

Providing Educational Information About Pulmonary Hypertension

The mission of PulmonaryHypertensionRN.com is to provide an informative and educational resource for pulmonary hypertension patients, their families, friends and loved ones.  The site aims to educate and serve as a springboard for people seeking a better understanding of the disease, its symptoms, treatments and implications for daily life. All information on this site is reviewed and edited by a Medical Doctor and Registered Nurse specializing in pulmonary hypertension.

Jeremy Feldman, MD

Dr. Jeremy FeldmanDr. Jeremy Feldman attended University of California San Diego for medical school and then trained in Internal Medicine at Harvard’s Brigham and Women’s Hospital. He continued on to University of California San Francisco for pulmonary and critical care training. He completed his fellowship at Stanford University where he was the Ebay Fellow in Pulmonary Vascular Disease.

Dr. Feldman’s involvement in pulmonary vascular disease dates to his residency at Harvard where he completed a mini-fellowship in Venous Thrombo-embolism with Dr. Goldhaber. He then worked with Dr. Demarco at UCSF and finally at Stanford University he worked closely with Dr. Feinstein and Dr. Doyle.

Since completing his training and relocating to Arizona in 2004, Dr. Jeremy Feldman and Dr. Greg Ahearn have built one of the largest pulmonary hypertension centers of excellence in the United States. He is nationally recognized as a leader in pulmonary hypertension and has been on the forefront of aggressive combination therapy. Dr. Feldman has developed a premier research program advancing the care of patients with pulmonary hypertension.

Dr. Feldman’s clinical interests include pulmonary vascular disease, complex hemodynamics, interstitial lung disease and dyspnea of obscure etiology.

When not working, Dr. Feldman enjoys cooking, the company of his two standard poodles and his new bride. He can be found exercising in the gym and enjoying delicious ethnic food around the valley.

Information, Not Medical Advice

While this site always strives to provide accurate and educational information, it is not a substitute for the advice or diagnosis of a qualified physician and should not be relied upon as such. Always consult your doctor with any questions and before making any decisions regarding your health. All matters regarding your health require the medical supervision of your physician. 

PAH Life Expectancy

PAH Research

Research, Life Expectancy & Prognosis for PH

Major Developments in Pulmonary Hypertension Affecting Prognosis 1.     Approval of

Where to Get Treatment?

CCCs for PAH

Pulmonary Hypertension Centers

Where to get treatment for pulmonary hypertension? Pulmonary arterial hypertension is a

Popular Posts

Blood tests to monitor PH patients

What is BNP?

By Dr. Jeremy Feldman

BNP stands for B-type natriuretic peptide. This is a hormone that is released by the bottom two chambers of the heart

News about PAH

Liquidia Files for Approval of Inhaled Treprostinil

By Dr. Jeremy Feldman

We were excited to hear that Liquidia has filed with the FDA for approval of their drug inhaled treprostinil. They had

good news in pah

 

Disclaimer

Recent Blog Posts

  • Sotatercept Coming Soon January 10, 2023
  • Why Abortion Matters to PAH Patients May 3, 2022
  • Aerovate and Inhaled Imatinib February 13, 2022

Categories

Archives